Company Encyclopedia
View More
name
Black-Hlth Sci T
BME.US
News
View More

Top Executive Makes Noteworthy Move with Stryker Stock!

Stryker's VP & CFO Preston Wendell Wells sold 165 shares for $60,370. Stryker's Q3 earnings showed 9.5% organic sales growth and 11.1% EPS increase. Despite challenges like tariffs and supply chain issues, Stryker raised its guidance. Analysts adjusted price targets, and Spark rates SYK as Outperform, noting strong fundamentals but bearish technical trends.

Tip Ranks·
US
SYK
-1.03%
Tip Ranks·
US
SYK
-1.03%

Why the Stock Price of This Cancer Screening Company Soared 17% Thursday

Abbott Laboratories has agreed to acquire Exact Sciences Corp. for $21 billion, paying shareholders $105 per share. Exact Sciences, known for its cancer screening tests like Cologuard, expects to generate about $3 billion in revenue this year. This acquisition is part of a broader trend of pharmaceutical companies investing heavily in cancer screening development.

MSN·
US
EXAS
+16.81%
US
ABT
-1.73%
MSN·
US
EXAS
+16.81%
US
ABT
-1.73%

With UnitedHealth Stock (UNH) Down Over 38%, Let's Look at Who Owns It

UnitedHealth Group (UNH) stock has dropped over 38% this year due to high medical costs and a DOJ investigation. Despite this, the company reported strong Q3 results and raised its earnings outlook. Analysts remain optimistic about its growth. Berkshire Hathaway's purchase of over 5 million shares shows confidence in UNH. Currently, public companies and individual investors own 49.17% of UNH, followed by mutual funds, ETFs, other institutional investors, and insiders.

Tip Ranks·
US
UNH
+0.79%
Tip Ranks·
US
UNH
+0.79%

Health Care Down, But not by Much, Amid Deal Activity -- Health Care Roundup

Health-care companies fell slightly amid deal activity. Exact Sciences surged after Abbott Laboratories agreed to acquire it for $21 billion. Moderna aims to stop losing money by 2028, despite taking a $1.5 billion loan. A CDC webpage now suggests vaccines might cause autism, reflecting changes under Health and Human Services Secretary Robert F. Kennedy.

marketscreener·
US
ABT
-1.73%
US
EXAS
+16.81%
US
MRNA
-7.53%
marketscreener·
US
ABT
-1.73%
US
EXAS
+16.81%
US
MRNA
-7.53%

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

TherapeuticsMD Inc. (TXMD) stock surged 16.36% to $1.92 on Thursday, outperforming competitors despite a poor trading session for the market. The NASDAQ fell 2.15% and the Dow Jones dropped 0.84%. This marks the third consecutive day of gains for TXMD, which closed 21.31% below its 52-week high. Trading volume exceeded its 50-day average. AbbVie Inc. (ABBV) fell 1.49%.

Dow Jones·
US
TXMD
+16.36%
US
ABBV
-1.49%
Dow Jones·
US
TXMD
+16.36%
US
ABBV
-1.49%